Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients

Part of paid clinical trials in Palo Alto, California.

Sponsor
University of California, San Diego
Study ID
NCT05705219
Status
Recruiting

Conditions

  • Liver Cancer, Adult

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • 3D-MPUS — DIAGNOSTIC_TEST
    Participants will receive approximately \< 20 minutes ultrasound scan to locate the lesion followed by acquisition of 3D-MPUS acquisition.

Study Details

This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.

Key Dates

First listed
Jan 30, 2023
Start date
Dec 4, 2023
Status verified
Jan 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2028

Study Design

Enrollment
80 participants (estimated)

Arms

  • Arm: 3-dimensional multi-parametric ultrasound imaging (3D-MPUS)
    Participants will receive sulfur hexafluoride IV and undergo 3D-MPUS imaging over 20 minutes.

Primary Outcome Measure

Diagnostic yield of the 3D-MPUS data acquisition [ Time Frame: Baseline visit ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Stanford University, School of MedicinePalo AltoCalifornia94305
David Marcellus, BS
(650) 723-4547
Aya Kamaya, MD (PRINCIPAL_INVESTIGATOR)
University of California, San DiegoSan DiegoCalifornia92037
Suzanna Lee
+1(858)-534-1475
Ahmed El Kaffas, PhD (PRINCIPAL_INVESTIGATOR)
Thomas Jefferson HospitalPhiladelphiaPennsylvania19107
Andrej Lyshchik, MD, PhD (PRINCIPAL_INVESTIGATOR)
John Eisenbrey, PhD (SUB_INVESTIGATOR)

Find similar trials in Palo Alto, CA

Related Studies